Search Results - April Armstrong

Refine Results
  1. 1

    Correction: Health Outcome Measures in Atopic Dermatitis: A Systematic Review of Trends in Disease Severity and Quality-of-Life Instruments 1985–2010. by Balvinder Rehal, April Armstrong

    Published in PLoS ONE (2011-01-01)
    Get full text
    Article


  2. 2

    Increased pin diameter improves torsional stability in supracondylar humerus fractures: An experimental study by Anupam Pradhan, William Hennrikus, Gregory Pace, April Armstrong, Gregory Lewis

    Published in Journal of Children's Orthopaedics (2016-04-01)
    Get full text
    Article


  3. 3

    Patient Perspectives on the Prevalence and Burden of Intertriginous Psoriasis: Results from a National Survey of Adults with Psoriasis in the United States by Teri Greiling, Melodie Young, Melissa S. Seal, Robert C. Higham, April Armstrong

    Published in Dermatology and Therapy (2024-06-01)
    Get full text
    Article


  4. 4

    Brodalumab to the Rescue: Efficacy and Safety of Brodalumab in Patients with Psoriasis and Prior Exposure or Inadequate Response to Biologics by Alan Menter, April Armstrong, Abby Van Voorhees, Clive Liu, Abby Jacobson

    Published in Dermatology and Therapy (2020-06-01)
    Get full text
    Article


  5. 5

    Treatment burden and the perspectives of patients with psoriasis using topical treatments: results from a national survey of adults with psoriasis in the United States by April Armstrong, Melodie Young, Melissa S. Seal, Robert C. Higham, Teri Greiling

    Published in Journal of Dermatological Treatment (2024-12-01)
    Get full text
    Article


  6. 6

    The More Things Change, the More They Stay the Same by Sandra Jarvis-Selinger, PhD, April Armstrong, MD, FAOA, Katherine Wisener, MA

    Published in JBJS Open Access (2023-06-01)
    Get full text
    Article


  7. 7

    The most effective corticosteroid dose in the treatment of glenohumeral osteoarthritis: Feasibility pilot and protocol for double blinded randomized controlled trial by Cayce Onks, Lynn Weaver, Johan Latorre, Matthew Silvis, Arthur Berg, Shawn Phillips, Jayson Loeffert, Cristy French, April Armstrong

    Published in Osteoarthritis and Cartilage Open (2024-09-01)
    Get full text
    Article


  8. 8

    Long-Term Efficacy and Safety of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: Updated Systematic Literature Review and Network Meta-analysis by Richard B. Warren, Kerry Donnelly, Sandeep Kiri, Vanessa Taieb, Mahmoud Slim, Kyle Fahrbach, Binod Neupane, Marissa Betts, April Armstrong

    Published in Dermatology and Therapy (2024-11-01)
    Get full text
    Article


  9. 9

    Metformin does not decrease the incidence of shoulder arthroplasty in patients with glenohumeral joint osteoarthritis by Tarek Haj Shehadeh, MD, Jawaad Chaudhry, BS, Ahmed Abdeen, BS, Gary Updegrove, MD, April Armstrong, MD, Nathan Lanham, MD

    Published in JSES Reviews, Reports, and Techniques (2025-11-01)
    Get full text
    Article


  10. 10

    Calcipotriene and Betamethasone Dipropionate PAD-Cream Demonstrates Greater Treatment Efficacy in Patients with Moderate-to-Severe Psoriasis Compared to Topical Suspension/Gel: A S... by Linda Stein Gold, Andreas Pinter, April Armstrong, Matthias Augustin, Petr Arenberger, Neil Bhatia, Morten Praestegaard, Lars Iversen, Adam Reich

    Published in Dermatology and Therapy (2023-07-01)
    Get full text
    Article


  11. 11

    Lebrikizumab is associated with improvements in patient-reported symptoms and quality-of-life measures across Eczema Area and Severity Index response categories: pooled results fro... by Andrew Blauvelt, Leon Kircik, Todd Schlesinger, Evangeline Pierce, Russel Burge, Michael Behling, Amber Reck Atwater, Hany ElMaraghy, April Armstrong

    Published in Journal of Dermatological Treatment (2025-12-01)
    Get full text
    Article


  12. 12

    Efficacy of risankizumab across subgroups in patients with active psoriatic arthritis: a post hoc integrated analysis of the phase 3 KEEPsAKE 1 and KEEPsAKE 2 randomized controlled... by Joseph F. Merola, April Armstrong, Saakshi Khattri, So Yeon Paek, Byron Padilla, Cuiyong Yue, Huzefa Photowala, Blair Kaplan, Lars Erik Kristensen

    Published in Journal of Dermatological Treatment (2024-12-01)
    Get full text
    Article


  13. 13

    Real-World Skin Clearance and Quality of Life with risankizumab in Patients with Psoriasis with Moderate Skin Involvement and Those Eligible for Systemic Therapy Per International... by Bruce Strober, Manish Patel, Mark I. Kaldas, Greg St. John, Huzefa Photowala, Adam P. Sima, Thomas Eckmann, Alicia Beeghly, April Armstrong

    Published in Dermatology and Therapy (2025-07-01)
    Get full text
    Article


  14. 14

    Telemedicine and psoriasis: A review based on statements of the telemedicine working group of the International Psoriasis Council by Mohamed H. M. El Komy, Andrea Chiricozzi, Peter van deKerkhof, April Armstrong, Vahid Diamei, Christophe Hsu, Joel Gelfand, Alexander A. Navarini

    Published in JEADV Clinical Practice (2023-03-01)
    Get full text
    Article


  15. 15

    Comparing Achievement of National Psoriasis Foundation Treatment Targets among Patients with Plaque Psoriasis Treated with Ixekizumab versus Other Biologics in Clinical and Real-Wo... by April Armstrong, Alvaro González-Cantero, Saakshi Khattri, Guilherme Muzy, William N. Malatestinic, Anastasia Lampropoulou, Meghan Feely, Sophia Kyoungah See, Can Mert, Andrew Blauvelt

    Published in Dermatology and Therapy (2024-03-01)
    Get full text
    Article


  16. 16

    Sustained Improvements in Clinical and Patient-Reported Outcomes and Quality of Life Through 5 Years Among Ixekizumab-Treated Patients with Complete Clearance of Scalp Psoriasis by... by Alexander Egeberg, Jason E. Hawkes, Najwa Somani, Russel Burge, Kyoungah See, Gaia Gallo, Missy McKean-Matthews, Melinda Gooderham, George Han, April Armstrong

    Published in Dermatology and Therapy (2024-04-01)
    Get full text
    Article


  17. 17

    Skin Clearance is Associated with Reduced Treatment Failure in Patients with Psoriasis: Real-World Evidence from the CorEvitas Psoriasis Registry by Robert R. McLean, Adam P. Sima, Silky Beaty, Robert Low, Rebecca L. Spitzer, Jeffrey L. Stark, Elizabeth Lesser, Edward Lee, April Armstrong

    Published in Dermatology and Therapy (2023-09-01)
    Get full text
    Article


  18. 18

    Benefits of Earlier Apremilast Initiation in Patients with Psoriasis and Limited Skin Involvement: Results from a Real-World Retrospective Study by April Armstrong, Bruce Strober, Paolo Gisondi, Kate K. Orroth, Myriam Cordey, Shia T. Kent, Cynthia Deignan, Shauna Jardon, Rohini K. Hernandez, M. Alan Brookhart, Linda Stein Gold

    Published in Dermatology and Therapy (2025-08-01)
    Get full text
    Article


  19. 19

    Durability of Near-Complete Skin Clearance in Patients with Psoriasis Using Systemic Biologic Therapies: Real-World Evidence from the CorEvitas Psoriasis Registry by Robert R. McLean, Adam P. Sima, Silky Beaty, Eric A. Jones, Thomas Eckmann, Robert Low, Laura McClung, Rebecca L. Spitzer, Jeffrey Stark, April Armstrong

    Published in Dermatology and Therapy (2023-09-01)
    Get full text
    Article


  20. 20

    Lebrikizumab Improves Quality of Life and Patient-Reported Symptoms of Anxiety and Depression in Patients with Moderate-to-Severe Atopic Dermatitis by Peter A. Lio, April Armstrong, Jan Gutermuth, Audrey Nosbaum, Howard Sofen, Esther Garcia Gil, Marta Casillas, Sherry Chen, Luna Sun, Evangeline Pierce, Hany Elmaraghy, Zach Dawson, Tiago Torres

    Published in Dermatology and Therapy (2024-06-01)
    Get full text
    Article


Search Tools: